MULTIPLEX IMMUNO-FLORESCENCE ASSAYS
Learn more about what is happening in the tumor microenvironment of your tissue sample
WEBCAST: Tissue-Based CDx Development and Image Analysis in a Regulated Space June 22, 2021 I 1:00pm EDT / 10:00am PDT
Our sophisticated tissue image analysis gives you a distinct advantage in drug development and clinical diagnostics
Powered by award-winning, proprietary technology and a multidisciplinary team of experts, Flagship Biosciences brings simplicity to a complicated pathology world.
From developing and validating an assay to employing the most comprehensive image analysis data, we provide a full, end-to-end solution for discovering and contextualizing the most relevant endpoints in a CAP/CLIA or RUO setting.
Our approach uses cell-based tissue data, rather than simple pixel data, to provide more accurate information for every sample. Flagship’s unique technology, team, and proven process have reported superior data for hundreds of clinical trials.
The Flagship approach:
- Saves time and money in predicting patient response and demonstrating mechanisms of action
- Dramatically improves accuracy
- Accelerates the development process through more robust data
- Enriches the clinical diagnostics decision-making process
Quite simply, we’re changing the drug development paradigm.
Our Services
Pharma
Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.
Clinical Diagnostics
Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.
Download our recent white paper,
“Tissue Image Analysis and Biomarker Assessment Implementation Benefits and ROI”
Benefits of Collaborating with Flagship
More accurate and informative tissue data and analytics
Collaboration with our world-renowned scientific team
Increased speed to market for your drug development programs
Enriched clinical diagnostics process for better outcomes
